Immuneel Therapeutics (Immuneel) has entered into a collaboration and licensing agreement with Hospital Clinic de Barcelona (HCB) and Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) for treatment of B cell malignancies.

The collaboration opens up opportunities for co-development of advanced assets to be deployed in Spain and India, Immuneel acquired the exclusive rights to develop and commercialise autologous ARI-0001 – a CD19 Chimeric antigen receptor (CAR) T cell therapy, in India.

This agreement puts Immuneel in the pursuit of offering accessible and affordable CAR Ts to patients in India through registration clinical trials and its investments in further process optimisation.

Kiran Mazumdar Shaw, Co-founder, Immuneel, said, “This partnership with HCB & IDIBAPS is pathbreaking and heralds the advent of life saving CAR T therapy for patients in India. Immuneel is committed to providing affordable access to this therapy at facilities housed at the Mazumdar Shaw Cancer Centre. I would

Read More

  • Coronavirus patients are asking to join clinical trials of antibody-based drugs after President Trump was given an experimental antibody therapy.
  • Regeneron, the company that made the antibody cocktail given to Trump, told Business Insider that “generally we have seen an uptick in clinical trial interest overall in recent weeks.”
  • And Reuters reported that doctors connected to Regeneron’s testing process saw more patients come forward wanting to be part of antibody trials after Trump, according to Reuters.
  • Regeneron’s antibody cocktail has not yet been approved by regulators and is only available to those taking part in the trial.
  • Trump has praised Regeneron’s treatment and called it a “cure,” though the company itself does not describe it as a cure and there is no evidence that this treatment has helped his condition.
  • A doctor in a hospital where Regeneron treatments are tested said there is still not enough evidence to justify antibody
Read More

  • President Trump told Fox News on Friday that he is “medication-free” and that he would donate plasma to help other coronavirus patients if asked.
  • “If that’s if they want me to do it, I’d love to do it,” Trump told Fox News medical expert, Dr. Marc Siegel when asked if he would donate plasma to those who need it. 
  • In the interview, Trump also said he had been retested for the virus on Friday, but said he didn’t know what the result was yet. 
  • Requirements for donating plasma are strict and donors must have a clinical COVID-19 diagnosis and be symptom-free for at least two weeks. 
  • Visit Business Insider’s homepage for more stories.

President Trump told Fox News that his treatment for COVID-19 has ended that he would donate plasma to help other patients if asked.

In his first on-camera interview since being diagnosed with the coronavirus, Trump told Fox

Read More

A Regeneron executive and one of its directors sold $1 million worth of stocks two days after President Donald Trump announced he was taking their therapeutic, recent filings from the Securities and Exchange Commission reveal.

Last Friday night, the White House announced that as part of Trump’s treatment for coronavirus, he had received Regeneron’s experimental antibody cocktail that has not passed formal trials or been approved by the Food and Drug Administration.

One day later, the president appeared in a video posted to his Twitter account about his treatment at Walter Reed National Military Medical Center.

“They gave me Regeneron,” he said, saying the company name instead of the treatment’s name, REGN-COV2. “It was like, unbelievable. I felt good immediately. I felt as good three days ago as I do now.”

At another point in the video he said that the therapeutics he was given were “miracles…we have things happening

Read More

US President Donald Trump said in a video from his hospital room on Saturday that he felt “much better” and hoped to be “back soon,” after a day of contradictory messages from the White House about his condition following his COVID-19 diagnosis.

In a four-minute video posted on Twitter, Trump, looking tired and wearing a jacket and open-necked shirt, said he “wasn’t feeling so well” when he first arrived at Walter Reed National Military Medical Center on Friday, and that the next few days would be crucial in his fight against the coronavirus.

 

“Over the next period of a few days, I guess that’s the real test, so we’ll be seeing what happens over those next couple of days,” Trump said, seated at a round table in front of an American flag.

The address came hours after differing assessments of his

Read More

  • President Trump is being treated for the coronavirus at Walter Reed Medical Center after announcing his diagnosis on Friday.
  • Trump received an IV infusion of the antiviral drug remdesivir on Friday.
  • A White House official told CBS News that Trump also received an experimental antibody cocktail on Thursday evening, but Trump’s medical team has suggested that he received the drug either earlier or later than that.
  • Regardless of the timing, a remdesivir treatment suggests Trump’s illness could be serious, doctors say.
  • Visit Business Insider’s homepage for more stories.

President Donald Trump is “doing very well” at Walter Reed Medical Center, the president’s doctors said on Saturday morning. After his Friday announcement that he’d tested positive for the coronavirus, Trump was reportedly experiencing a low-grade fever, cough, lethargy, and nasal congestion. 

“At this time, the team and I are extremely happy with the progress the president has made,” White House physician

Read More

President Donald Trump received Regeneron’s experimental antibody drug after testing positive for the novel coronavirus.

On Friday, the president said he and first lady Melania Trump tested positive for the virus and began isolating. The White House said the president was fatigued, and The New York Times reported that he had mild coldlike symptoms.

Trump, 74, is at an increased risk for a more serious case of COVID-19 because of his age, weight, and sex. On Friday evening, he was headed to Walter Reed National Military Medical Center, where he plans to stay for several days. White House press secretary Kayleigh McEnany said the decision was made “out of an abundance of caution.” 

In a memo released Friday, White House physician Sean Conley said Trump had received an injection of 8 grams of Regeneron’s drug, which is a combination of two antibodies and called REGN-COV2. Antibodies are disease-fighting proteins that

Read More

WASHINGTON — According to a letter sent to New York lawmakers late Wednesday, the U.S. Treasury Department has agreed to stop siphoning cash away from the Fire Department’s 9/11 treatment program, but it remains unclear when or if the FDNY would get its missing money back.

The federal agency began docking payments meant to care for ill firefighters and EMTs back in 2016 in a move that was never explained to the FDNY’s World Trade Center Treatment program.

In all, FDNY Chief Medical Officer Dr. David Prezant estimates that $3.7 million that was sent to his program by the National Institute of Occupational Safety and Health simply vanished in transit.

After years of investigation, he learned the Treasury Department was taking the money, apparently to satisfy a wholly unrelated debt dispute between the city and the Centers for Medicare and Medicaid Services, or CMS.

The Treasury Department initially said it

Read More

The MarketWatch News Department was not involved in the creation of this content.

Sep 27, 2020 (CDN Newswire via Comtex) —
Global Periodic Paralysis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 comprises the past, current, and projection size of the market. The report provides an in-depth segment analysis of the market, providing valuable insights to the rivals. The report covers various domestic vendors in the global Periodic Paralysis Treatment market with a competitive scenario. The study document is distributed inside this examination, comprehensive of things like the business size concerning value and volume during the forecast period from 2020 to 2025. The report includes numbers, subdivisions, revenue, and shares as well as the exhaustive calculation of the industry chain structure, market drivers, opportunities, industry news analysis, and industry policy analysis.

Our top experts have studied the market with the reference of data given by the

Read More

NEW YORK (AP) — Lowe’s is offering small businesses, particularly those owned by minorities, the “Shark Tank” treatment.

The home improvement chain is teaming up with Daymond John, star of ABC’s “Shark Tank,” to give potential suppliers the chance to pitch their products to a Fortune 500 company.

That will allow a small number of entrepreneurs to pitch their products directly to Lowe’s, sidestepping a traditionally arduous process of getting their goods sold in 2,200 stores run by the Mooresville, North Carolina company, and on lowes.com.

From Tuesday through Sept. 25 small business owners can apply. Lowe’s is putting an emphasis on businesses run by the disabled, people of color and people in the LGBT community. Candidates will be narrowed down to 75, who will then be allowed to submit more in-depth pitches via video.

Five finalists will make a live virtual pitch, hosted by John, to Lowe’s CEO

Read More